Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 2.26 | 2.26 |
NAV | ₹14.75 | ₹165.23 |
Fund Started | 26 Jul 2023 | 13 Oct 2005 |
Fund Size | ₹869.36 Cr | ₹1429.17 Cr |
Exit Load | Exit load of 1%, if redeemed within 15 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -12.65% | 7.64% |
3 Year | - | 23.31% |
5 Year | - | 25.90% |
1 Year
3 Year
5 Year
Equity | 92.24% | 90.29% |
Cash | 3.19% | 9.01% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Reliance Industries Ltd. | 9.69% |
Aurobindo Pharma Ltd. | 8.19% |
Samvardhana Motherson International Ltd. | 8.05% |
Grasim Industries Ltd. | 7.62% |
Zydus Wellness Ltd. | 5.61% |
Ravindra Energy Ltd. | 4.54% |
Himadri Speciality Chemical Ltd. | 4.50% |
Ador Welding Ltd. | 4.28% |
Laxmi Organic Industries Ltd. | 3.99% |
Bajaj Auto Ltd. | 3.96% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.99% |
Infosys Ltd. | 7.91% |
Reliance Industries Ltd. | 6.34% |
NTPC Ltd. | 4.77% |
HDFC Bank Ltd. | 4.59% |
Bharti Airtel Ltd. | 3.54% |
Sun Pharmaceutical Industries Ltd. | 3.42% |
State Bank of India | 3.29% |
Larsen & Toubro Ltd. | 3.13% |
Dr. Reddy's Laboratories Ltd. | 3.06% |
Name | Ankit A Pande | Sri Sharma |
Start Date | 11 May 2020 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing in equity and equity related instruments of companies that follow the manufacturing theme. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 26 Jul 2023 | 13 Oct 2005 |
Description
Launch Date